The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline
INDUCE-3: A randomized, double-blind study of GSK3359609 (GSK609), an inducible T-cell co-stimulatory (ICOS) agonist antibody, plus pembrolizumab (PE) versus placebo (PL) plus PE for first-line treatment of PD-L1-positive recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
 
Aaron Richard Hansen
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Merck; Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Merck; Novartis
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Thomas S. Stanton
Honoraria - Axess Oncology; Bristol-Myers Squibb; Intellisphere; Intellisphere; Ipsen; Ipsen
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Min Hee Hong
Stock and Other Ownership Interests - GI biome; GI cell
Honoraria - AstraZeneca; AstraZeneca; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Merck; Roche; Yuhan
Research Funding - Yuhan
 
Ezra E.W. Cohen
Consulting or Advisory Role - ALX Oncology; Ascendis Pharma; Bayer; BiolineRx; Bristol-Myers Squibb; Debiopharm Group; Dynavax Technologies; Merck; MSD; Regeneron; Sanofi
 
Hisham Mohamed Mehanna
Employment - Warwickshire Head and Neck Clinic
Leadership - Warwickshire Head and Neck Clinic; Warwickshire Head and Neck Clinic (I)
Stock and Other Ownership Interests - Warwickshire Head and Neck Clinic
Honoraria - AstraZeneca
Speakers' Bureau - Merck; MSD; Sanofi Pasteur
Research Funding - AstraZeneca; GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); MSD (Inst); Sanofi Pasteur (Inst); Silence Therapeutics (Inst)
Travel, Accommodations, Expenses - Merck; MSD; Sanofi Pasteur
 
Michael Jon Chisamore
Employment - Merck
Stock and Other Ownership Interests - Merck
 
David Turner
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Sapna Yadavilli
No Relationships to Disclose
 
Kelly Bell
Employment - GlaxoSmithKline; Humana Pharmacy (I)
Stock and Other Ownership Interests - CVS (I)
 
Carlos Baccan
Employment - Bristol-Myers Squibb; GlaxoSmithKline; PAREXEL
Stock and Other Ownership Interests - Bristol-Myers Squibb; GlaxoSmithKline
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; PAREXEL
 
Rosalida Leone
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Helen Chen
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Helen Zhou
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Catherine Elizabeth Ellis
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Marc S. Ballas
Employment - GlaxoSmithKline
Leadership - GlaxoSmithKline
Stock and Other Ownership Interests - Bristol-Myers Squibb; GlaxoSmithKline
Research Funding - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - AstraZeneca; GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Axel Hoos
Employment - GlaxoSmithKline
Leadership - Imugene
Stock and Other Ownership Interests - GlaxoSmithKline; Imugene
 
Danny Rischin
Research Funding - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Merck; Regeneron
Travel, Accommodations, Expenses - Merck